LV apex with hypokinesis in the basal to mid segments in 7 consecutive patients with endomyocardial biopsy-proven CA. Using 2D or 3-dimensional speckle tracking imaging (STI) technique, we and other groups recently reported that an intrawall longitudinal base-to-apex strain gradient may be detectable in the majority of patients with CA. [9] [10] [11] It remains unclear, however, whether this strain gradient pattern is specific for CA. Therefore, the purpose of the present study was to evaluate the diagnostic value of the septal systolic longitudinal strain in combination with diastolic parameters for differentiating CA from other causes of concentric LV hypertrophy.
Methods

Study Population
Consecutive patients with LV hypertrophy (ie, end-diastolic septal thickness ≥12 mm) experiencing CA, HP, FD, and FA (n=25 per group) were studied. In all patients with light-chain amyloidosis, ≥1 biopsy from endomyocardial tissue, bone marrow, rectum, kidney, or subcutaneous fat was positive for amyloid. The type of amyloid was assessed by immune histology. Patients with FD and FA were selected from the FD and FA reference centers of University Hospital of Würzburg, and all diagnoses were genetically confirmed. Hypertension was defined by a repeatedly measured systolic blood pressure ≥140 mm Hg or diastolic blood pressure ≥90 mm Hg or if the subject was receiving optimal antihypertensive pharmacotherapy based on current guidelines. 12 Patients with coronary artery disease, moderate to severe cardiac valve disease, and other endocrine or systemic diseases were excluded. Twenty-five healthy volunteers from the hospital staff and their relatives served as the control group. The study was approved by the local ethics committee and conducted in accordance with the Declaration of Helsinki. Informed consent was obtained from all patients.
Standard Echocardiography
LV end-diastolic and end-systolic dimensions, as well as end-diastolic thickness of the posterior wall and the septum, were measured using standard M mode in parasternal LV long-axis views. LV ejection fraction (EF) was measured with the biplane Simpson method in apical 4-and 2-chamber views. Pulsed-wave Doppler was performed in apical 4-chamber views to obtain mitral valve inflow velocities for LV filling pattern evaluation (early filling [E wave] and late diastolic filling [A wave] velocities, E/A ratio, and deceleration time of early filling [DT]). Tissue Doppler early diastolic mitral annular velocity (E′) of the septal annulus was obtained in the apical 4-chamber view. Atrial fibrillation was present in 7 patients with CA, 2 patients with HP, and 2 patients with FD; in these subjects, E, E′, and DT (averaged from 3 cardiac circles) were measured. The stage of LV diastolic function was diagnosed according to the American Society of Echocardiography guidelines for the assessment of diastolic function. 13
Speckle Tracking Imaging
All longitudinal segmental strain measurements were preformed offline using dedicated software (EchoPAC; GE, Horten, Norway). The 2D gray-scale images were recorded with a frame rate of 60 to 80 frames per second, and care was taken to ensure that the entire ventricular wall was clearly visible in all frames. A region of interest was created by manually outlining the endocardial border on an apical 4-chamber view at the end-systolic frame. The system automatically tracked the tissue within the region and divided the myocardium into standard segments. The tracking was visually checked and, if necessary, adjusted. The trace analysis was automatically displayed after validating the tracking. LV longitudinal peak systolic strain (LSsys) was extracted from basal, mid, and apical segments of the septum.
The ratio between apical LSsys and basal LSsys (LSsys api/bas ) was calculated as apical LSsys divided by basal LSsys.
Electrocardiography
A standard 12-lead ECG was recorded from each patient, with a paper speed of 50 mm/s and an amplification of 0.1 mV/mm. Low QRS voltage was defined as <0.5-mV peak-to-peak QRS amplitudes in each limb lead and <1.0 mV in each precordial lead. 14 LV hypertrophy was defined by the Sokolow-Lyon criterion; that is, the sum of the S wave in V 1 and the R wave in V 5 or V 6 is ≥3.5 mV. 15 A pseudoinfarct pattern was defined as a QS wave pattern in 2 contiguous leads in the absence of previous myocardial infarction.
Cardiac MRI
Cardiac MRI was performed with a 1.5-T scanner (Magnetom Symphony Quantum, Siemens) using 2 conventional 6-channel body phased-array coils (Siemens, Erlangen, Germany) for signal detection. A stack of 15 slices ensured coverage of the whole LV. Late enhancement (LE) was obtained 10 to 15 minutes after the injection of 0.2 mmol/kg gadopentetate dimeglumine using an inversion recovery 2D turbo gradient echo sequence.
Data Analysis
Continuous data are presented as mean±SD and categorical variables as percentages. Differences in continuous data among the 5 patient groups were compared using 1-or 2-way ANCOVA after normalization if indicated, followed by appropriate post hoc tests for multiple comparisons (Tukey if equal variances assumed; Games-Howell if equal variances not assumed). Nonnormally distributed variables were normalized before analysis using natural logarithm or inverted values. Categorical data were compared across groups with a similar approach using the χ 2 test for the overall test and Fisher exact for pairwise group tests, as appropriate. Because we aimed to contrast CA patients with control subjects and the other 3 patient groups, statistical significance was assumed at Bonferroni-adjusted P<0.0125 (Tables 1 and 2) and P<0.0166 (Table 3) , respectively. Pairwise comparisons were only performed if the global test was significant.
Receiver-operating characteristic (ROC) analysis was performed to identify the diagnostic yield of LSsys gradient and diastolic parameters for CA, respectively. The cutoff value of septal LSsys api/bas was derived from ROC analysis by maximizing the sum of the sensitivity and specificity. For this cutoff value, the 95% confidence interval (CI) was computed using the bias-corrected and accelerated method (with 10 000 bootstrap resampling steps) as described by DiCiccio and Efron 16 and as implemented in MedCalc Software (version 12.7.2; last modified, August 2013; Ostend, Belgium). Diagnostic performance measures are reported as mean with their 95% CIs. Further statistical analysis was performed using IBM SPSS, version 20 for Windows (SPSS).
Results
Clinical Characteristics
Patients with FA were significantly younger compared with other patient groups and control subjects ( Table 1) . One patient with CA experienced pulmonary embolism with subsequent pulmonary infarction, and 1 patient experienced deep vein thrombosis of the leg. Although not systematically sought for, no intracardiac thrombus formation was detected in patients with CA using conventional echocardiography (n=25), transesophageal echocardiogram (n=1), or cardiac MRI (n=12). Contrastenhanced cardiac MRI was performed in 12 patients with CA, 2 patients with HP, 20 patients with FD, and 5 patients with FA in this cohort. LE was documented in 9 of 12 patients with CA (75%; 7 diffuse, 1 basal posterolateral wall, 1 basal septal and anterior wall), in 16 of 20 patients with FD (80%; 6 diffuse, 10 with patchy distribution in the LV and located predominantly in the posterolateral region), and in all 5 patients with FA (100%; 5 diffuse), but in none of the patients with HP (0%).
Standard Echocardiographic Evaluation
Standard echocardiographic parameters are listed in Table 1 . LV wall thickness and LV EF (all >55%) were similar among the 4 patient groups. DT was significantly shorter in the CA group than that in the control, HP, and FD groups. E/E′ was significantly higher in the CA group than in the control, HP, and FA groups. ROC analysis showed that DT outperformed E/E′ in differentiating CA from HP, FD, and FA. The areas under the ROC curve for DT and E/E′ were 0.86 (95% CI, 0.78-0.94) and 0.79 (95% CI, 0.67-0.90), respectively. Advanced diastolic dysfunction (pseudonormal or restrictive pattern) was absent in the control and FA groups but was observed in 76% of patients with CA, 16% with HP, and 48% with FD. Figure 1 illustrates examples of STI-derived longitudinal strain curves at apical, mid, and basal segments of the septum from a normal subject and patients with CA, HP, FD, and FA. Mean values for septal apical LSsys were similar among all patient groups and control subjects. However, septal mid and basal LSsys values were significantly lower in the CA group than in the control, HP, FD, and FA groups. Consequently, the septal LSsys api/bas ratio was significantly higher in the CA group than in all other groups ( Table 2 ). To better understand the relationship between regional myocardial function and morphology of the septum, the regional septal wall thickness was measured in 2D images from an apical 4-chamber view.
Septal Longitudinal Systolic Strain
In the CA group, the septal end-diastolic wall thickness was significantly higher at the basal and mid segments compared with apical segments. A trend for the same finding was also seen in HP and FD groups ( Table 2 ).
Electrocardiography
As shown in Table 3 , low QRS voltages and QRS pseudoinfarct changes were more frequently seen in the CA group than in the HP, FD, and FA groups (P<0.05). LV Sokolow index was significantly lower in the CA group than in other patient groups. Fifty percent of patients with FD presented more severe LV hypertrophy assessed by ECG criteria. Conversely, LV hypertrophy was suggested in none of patients with CA and in only 16% of patients with HP by ECG.
Diagnostic Use of LSsys api/bas and DT
The diagnostic performance of LSsys api/bas was optimal at a cutoff value of 2.1 (bootstrapped 95% CI, 1.32-2.19; Figure 2 , left), differentiating CA from HP, FD, and FA with a sensitivity, specificity, positive predictive value, and negative predictive value of 88% (68%-97%), 85% (75%-92%), 67% (48%-81%), and 96% (87%-99%), respectively. The corresponding area under the ROC curve was 0.91 (95% CI, 0.83-0.96; Figure 2 , left). The prevalence of septal LSsys api/bas >2.1 in patients with CA (88%) was significantly higher than in the control (0%), HP (32%), FD (12%), and FA (0%) groups (Figure 2, right) . Figure 3 shows that the prevalence of LSsys api/bas >2.1 plus a DT <200 milliseconds was 88% in the CA group but 0% in the control and all other patient groups (sensitivity, 88%; specificity, 100%; positive predictive value, 100%; negative predictive value, 96%).
Discussion
The major finding of this study is that a systolic septal longitudinal base-to-apex strain gradient (LSsys api/bas >2.1), combined with a shortened diastolic DT (DT <200 milliseconds), could be used to differentiate CA from other forms of concentric LV hypertrophy such as HP, FD, and FA.
Longitudinal Base-to-Apex Strain Gradient in CA Patients With Preserved EF
The diagnosis of CA remains a clinical challenge, requiring cardiac biopsy and histological evaluation to arrive at a definite diagnosis; however, histology is not available in several patients with suspected CA. It is therefore important to find noninvasively derived sensitive and specific diagnostic markers that aid in the diagnostic workup of CA. Conventional echocardiography has been used to identify the structural and functional changes of patients with CA. 1, [17] [18] [19] However, typical conventional echocardiographic findings suggestive for the diagnosis of CA mostly appear only in advanced stages and may be absent in individual patients with suspected CA. 13, 20 Two-dimensional STI is currently being developed as an objective methodology for the assessment of regional myocardial deformation and function in cardiovascular diseases. 21 Using the 2D STI technique, we recently demonstrated a pronounced intrawall longitudinal base-to-apex strain gradient with preserved LSsys at apical segments and significantly reduced LSsys at basal and mid segments in patients with CA. 11 This strain gradient is related to disease progression and is helpful in predicting the prognosis of patients with CA. In addition, the gradient was superior to other routine echocardiographic parameters such as LV wall thickness and EF for clinical staging. Nevertheless, it remains unknown whether the observed strain gradient in patients with CA is a pathognomonic feature for patients with CA or whether it is also present in other forms of concentric hypertrophy. In the present study, we found that this typical strain gradient pattern was present in the majority of patients with CA but not in patients with HP, FD, and FA with similar types of concentric LV hypertrophy. Consistent with our findings, Phelan et al 10 reported that the presence of relatively preserved apical longitudinal strain assessed by a 2D STI bull's-eye plot could differentiate patients with CA from patients with LV hypertrophy caused by hypertrophic cardiomyopathy and aortic stenosis. Baccouche et al 9 also demonstrated intrawall longitudinal regional strain gradient in patients with CA using 3-dimensional STI. However, the patients with CA enrolled in both of these studies were at the late stage of the disease with severe LV hypertrophy and significantly reduced EF. In our study, we focused on regional strain changes in patients with CA at an earlier stage with preserved EF (>55%).
Potential Mechanisms of the Longitudinal Strain Gradient
The underlying pathophysiology for the documented longitudinal base-to-apex systolic strain gradient in patients with CA might be multifactorial. The different wall stress faced by the septal basal, mid, and apical segments might contribute to the observed strain differences among these regions. It is known that the wall stress at the basal segment is higher than at the mid and apical segments because of the nonspherical ventricular geometry and the largest local radius of the LV curvature in the basal part of the septum. 22, 23 The propensity to develop increased apoptosis, collagen formation, and subsequent fibrosis might be higher in segments with elevated wall stress, 23 which may partly explain the phenomenon of significantly lower strain values of patients with CA at the basal compared with the apical segments. However, the factor of unequal wall stress is similarly encountered in patients with FD and FA and even more exaggerated in HP, where this additionally leads to significant postsystolic deformation at the basal septum ( Figure 1 ). 2 However, in CA, the increased wall thickness is caused by extracellular protein deposition, which is in contrast to the real cellular hypertrophy presented in patients with HP, FD, and FA. Thus, it can be speculated that the increased wall stress on segments, together with extracellular protein deposition, in CA might have much more effect on cardiac deformation than increased wall stress in patients with HP, FD, and FA with true cellular hypertrophy. The difference in wall thickness at the basal, mid, and apical segments might also play a role in the observed septal longitudinal base-to-apex strain gradient in patients with CA. Phelan et al 10 showed that the LV wall thickness determined by cardiac MRI at the basal and mid segments increased more than at the apex in patients with CA. This may indicate relatively less amyloid deposition in the apex. Brenner et al 24 reported that human light-chain proteins could directly impair active force through an increase in cellular oxidant stress. Thus, it is possible that less deformation impairment at the apical segment of patients with CA is linked to a lower amount of amyloid deposition at this region, resulting in the observed preserved longitudinal strain at the apical segment in patients with CA. A greater diversity of myocardial fibers and matrix orientations at the apical segment compared with the basal segment of patients with CA could also contribute to a preserved deformation at the apical segments. [24] [25] [26] It is of note that this strain gradient was also observed in 32% of the patients with HP. Interestingly, in 7 of 8 (87%) of these HP patients with a strain gradient, a septal bulge (localized increase in wall thickness of the basal septum) was detected. Thus, the inhomogeneity in morphology might be responsible for the detected septal longitudinal base-to-apex strain gradient in some of the patients with HP. In line with this finding, Baltabaeva et al 27 found that longitudinal peak systolic strain rate and end-systolic strain were significantly reduced at the basal septal segment, whereas they were preserved at mid and apical segments in patients with hypertension compared with nonhypertensive control subjects and that marked postsystolic thickening was present in that segment.
Diastolic Filling in Patients With CA
In early-stage CA with mild amyloid infiltration, the myocardial relaxation process is altered by calcium overload. 28, 29 In advanced CA, the severe amyloid infiltration of the ventricular walls and the subsequent remodeling and replacement fibrosis 19 finally lead to the stiff heart syndrome with a restrictive filling pattern. Although the specific longitudinal base-to-apex strain gradient was found in the majority of patients with CA, there was still a slight overlap between the CA group and the HP group. To further differentiate patients with CA from patients with HP, we complemented it with a routine echocardiographic parameter assessing diastolic function. Experimental and clinical studies suggested that DT of early diastolic filling is related to LV stiffness and that DT shortens in proportion to a decrease in LV compliance. 30, 31 Our study showed that complementing the systolic strain gradient with the DT parameter could improve the diagnostic accuracy for echocardiographic detection of CA.
Consistent with the cardiac MRI study by Syed et al, 32 we found that diffuse LE as a possible sign of interstitial deposition of amyloid was common in patients with CA (58% in our sample). In line with previous reports, our study underlines the notion that the presence and type of LE pattern are helpful in differentiating CA (diffuse LE) from FD (patchy LE) and hypertensive heart disease (no LE). 33
Clinical Impact
The present study indicates that combining an established conventional diastolic function parameter (DT) together with advanced systolic function parameters (peak systolic strain) could be a feasible strategy for differentiating CA from other causes of concentric LV hypertrophy. Short DT (<200 milliseconds) and higher septal LSsys api/bas ratio (>2.1) are suggestive of CA (specificity, 100%; sensitivity, 88%). These parameters are simple and available in patients with both sinus and atrial fibrillation rhythms. Hypertrophic patients suspected for CA could be identified by measuring DT and LSsys api/bas ratio during daily echocardiographic examinations.
Limitations
The patient sample was relatively small, which could have introduced some bias and subsequent overoptimism on the proposed cutoff values. Certainly, prospective studies with larger sample size are warranted to confirm these results and to test their relevance for clinical practice. In addition, not all types of hypertrophic conditions were included. However, hypertrophic cardiomyopathy is an asymmetrical hypertrophy and thus is relatively easily discernible from CA. Furthermore, in patients with aortic stenosis, the symmetrical hypertrophy is related to the aortic valve abnormalities that can be identified by conventional echocardiography. No intracardiac thrombus formation was detected in patients with CA, although autopsy and in vivo transesophageal echocardiogram studies suggest a prevalence rate between 15% and 30%. 34, 35 Because the systematic search for thrombotic disease was outside the focus of this investigation, the reason for this discrepancy may be related to the low specificity of transesophageal echocardiogram in detecting intracardiac thrombus.
Conclusions
The septal longitudinal base-to-apex strain gradient (LSsys api/bas >2.1), combined with a short DT (DT <200 milliseconds), is a good diagnostic parameter for differentiating CA from other causes of concentric LV hypertrophy.
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